Publications

Estimating the health impact of vaccination against ten pathogens in 98 low-income and middle-income countries from 2000 to 2030: a modelling study.

Li, X; MUKANDAVIRE, C; Cucunubá, ZM; Echeverria Londono, S; ABBAS, K; Clapham, HE; JIT, M; Johnson, HL; Papadopoulos, T; VYNNYCKY, E; Brisson, M; Carter, ED; CLARK, A; De Villiers, MJ; Eilertson, K; Ferrari, MJ; Gamkrelidze, I; Gaythorpe, KA M; Grassly, NC; Hallett, TB; Hinsley, W; Jackson, ML; Jean, K; Karachaliou, A; KLEPAC, P; ... Vaccine Impact Modelling Consortium,

2021

The Lancet, (2021).397 10272 10.1016/S0140-6736(20)32657-X.

Levels of pneumococcal conjugate vaccine coverage and indirect protection against invasive pneumococcal disease and pneumonia hospitalisations in Australia: An observational study.

Chan, J; Gidding, HF; Blyth, CC; Fathima, P; Jayasinghe, S; McIntyre, PB; Moore, HC; MULHOLLAND, K; Nguyen, CD; Andrews, R; Russell, FM;

2021

PLoS medicine, (2021).18 8 10.1371/journal.pmed.1003733.

Evaluating the potential economic and health impact of rotavirus vaccination in 63 middle-income countries not eligible for Gavi funding: a modelling study.

Debellut, F; CLARK, A; Pecenka, C; Tate, J; Baral, R; SANDERSON, C; Parashar, U; Atherly, D;

2021

The Lancet. Global health, (2021).9 7 10.1016/S2214-109X(21)00167-4.

Social contact information from PIPSA residents in uMkhanyakude before and during the Covid-19 pandemic – data from the Umoya Omuhle and Covid Social Contacts studies.

MCCREESH, N; Dlamini, V; Edwards, A; Olivier, S; Dayi, N; Dikgale, K; Nxumalo, S; Dreyer, J; BAISLEY, K; Siedner, MJ; WHITE, RG; Herbst, K; GRANT, AD; Harling, G;

2021

, AHRI Data Repository (2021).

Better data for country-level TB resource allocation are urgently required.

Clarkson, MC; MCQUAID, CF; HOUBEN, RM; KRANZER, K; WHITE, RG;

2021

The international journal of tuberculosis and lung disease : the official journal of the International Union against Tuberculosis and Lung Disease, (2021).25 8 10.5588/ijtld.20.0912.

Effect of evidence updates on key determinants of measles vaccination impact: a DynaMICE modelling study in ten high-burden countries.

FU, H; ABBAS, K; KLEPAC, P; VAN ZANDVOORT, K; TANVIR, H; Portnoy, A; JIT, M;

2021

BMC Medicine, (2021).19 1 10.1186/s12916-021-02157-4.

COVID-19 vaccination in Sindh Province, Pakistan: A modelling study of health impact and cost-effectiveness.

PEARSON, CA B; BOZZANI, F; PROCTER, SR; DAVIES, NG; Huda, M; JENSEN, HT; KEOGH-BROWN, M; Khalid, M; SWEENEY, S; TORRES-RUEDA, S; CHiL COVID-19 Working Group,; CMMID COVID-19 Working Group,; EGGO, RM; VASSALL, A; JIT, M;

2021

PLoS medicine, (2021).18 10 10.1371/journal.pmed.1003815.

Anti-Severe Acute Respiratory Syndrome Coronavirus 2 Immunoglobulin G Antibody Seroprevalence Among Truck Drivers and Assistants in Kenya.

Kagucia, EW; Gitonga, JN; Kalu, C; Ochomo, E; Ochieng, B; Kuya, N; Karani, A; Nyagwange, J; Karia, B; Mugo, D; Karanja, HK; Tuju, J; Mutiso, A; Maroko, H; Okubi, L; Maitha, E; Ajuck, H; Mukabi, D; Moracha, W; Bulimu, D; Andanje, N; Aman, R; Mwangangi, M; Amoth, P; Kasera, K; ... Magarini Sub-County TDA SARS-CoV-2 Serosurveillanc,

2021

Open Forum Infectious Diseases, (2021).8 7 10.1093/ofid/ofab314.

Interchangeability, immunogenicity and safety of a combined 10-valent pneumococcal Haemophilus influenzae protein D conjugate vaccine (Synflorix) and 13-valent-PCV (Prevenar13) schedule at 1-2-4-6 months: PREVIX_COMBO, a 3-arm randomised controlled tri...

Leach, AJ; MULHOLLAND, EK; Santosham, M; Torzillo, PJ; McIntyre, P; Smith-Vaughan, H; Wilson, N; Arrowsmith, B; Beissbarth, J; Chatfield, MD; Oguoma, VM; Licciardi, P; Skull, S; Andrews, R; Carapetis, J; McDonnell, J; Krause, V; Morris, PS;

2021

Vaccine: X, (2021).7, 10.1016/j.jvacx.2021.100086.

Durable natural killer cell responses after heterologous two-dose Ebola vaccination.

Wagstaffe, HR; Susannini, G; Thiébaut, R; Richert, L; Lévy, Y; Bockstal, V; Stoop, JN; Luhn, K; Douoguih, M; Riley, EM; Lacabaratz, C; GOODIER, MR;

2021

npj Vaccines, (2021).6 1 10.1038/s41541-021-00280-0.